Multiple growth factor and cytokine receptor

"Multiple growth factor and cytokine receptor" is not a specific molecule, but refers collectively to a broad set of **cell surface receptors** that respond to growth factors and cytokines. These receptors transmit extracellular signals into intracellular signaling cascades, regulating cell proliferation, differentiation, survival, immune responses, angiogenesis, and more[1][2][3][4][5]. Growth factor receptors are often **receptor tyrosine kinases** (e.g., epidermal growth factor receptor, fibroblast growth factor receptor, vascular endothelial growth factor receptor)[1][7]. Cytokine receptors include diverse families such as **Type I/II cytokine receptors**, tumor necrosis factor receptors, chemokine receptors (which are G protein–coupled receptors), and others[5]. Dysregulation of these pathways is closely associated with **cancer, autoimmune diseases, immunodeficiency, and inflammatory or fibrotic disorders**[1][2][3][5]. Though many **therapeutic agents target specific members** of these receptor classes, "multiple growth factor and cytokine receptor" is not a recognized standardized molecular target; it is a functional or descriptive grouping. For structured pharmacological or clinical annotation, one must refer to individual receptors by their canonical names (e.g., "Epidermal growth factor receptor," "Interleukin-6 receptor")[1][7][5][3].

Other names

Growth factor receptor familyCytokine receptor familyGrowth factor and cytokine receptor systems

Inhibition of receptor-ligand binding (antibody antagonists) Inhibition of receptor kinase activity (small molecule inhibitors) Ligand mimicry or competitive antagonism Modulation of downstream signaling cascades (JAK/STAT pathway inhibition, MAPK inhibition, PI3K/AKT inhibition)